Advertisement

Topics

FDA Approves Biotronik’s Thin-Strut Orsiro Coronary Stent

12:28 EST 22 Feb 2019 | SCRIP

Bioresorbable-polymer, sirolimus-eluting Orsiro outperformed Abbott’s market-leading Xience durable-polymer, everolimus-eluting stent at the two-year follow-up in the BIOFLOW V trial. The...

      

Related Stories

 

Original Article: FDA Approves Biotronik’s Thin-Strut Orsiro Coronary Stent

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Biotronik’s Thin-Strut Orsiro Coronary Stent"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Stent
A stent is a small mesh tube that's used to treat narrow or weak arteries. Arteries are blood vessels that carry blood away from your heart to other parts of your body.  A stent is placed in an artery as part of a procedure called angioplasty. &...